Literature DB >> 22298226

The 'Effects of Transfusion Thresholds on Neurocognitive Outcome of Extremely Low Birth-Weight Infants (ETTNO)' Study: Background, Aims, and Study Protocol.

.   

Abstract

Background: Infants with extremely low birth weight uniformly develop anemia of prematurity and frequently require red blood cell transfusions (RBCTs). Although RBCT is widely practiced, the indications remain controversial in the absence of conclusive data on the long-term effects of RBCT.
Objectives: To summarize the current equipoise and to outline the study protocol of the 'Effects of Transfusion Thresholds on Neurocognitive Outcome of extremely low birth-weight infants (ETTNO)' study.
Methods: Review of the literature and design of a large pragmatic randomized controlled trial of restrictive versus liberal RBCT guidelines enrolling 920 infants with birth weights of 400-999 g with long-term neurodevelopmental follow-up. Results and Conclusions: The results of ETTNO will provide definite data about the efficacy and safety of restrictive versus liberal RBCT guidelines in very preterm infants.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Year:  2012        PMID: 22298226     DOI: 10.1159/000335030

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  11 in total

1.  Red blood cell transfusions and potentially related morbidities in neonates under 32 weeks' gestation.

Authors:  Gabriele D'Amato; Maria F Faienza; Valentina Palladino; Francesco P Bianchi; Maria P Natale; Robert D Christensen; Paola Giordano; Antonio Del Vecchio
Journal:  Blood Transfus       Date:  2020-10-14       Impact factor: 3.443

Review 2.  Epidemiology of Necrotizing Enterocolitis: New Considerations Regarding the Influence of Red Blood Cell Transfusions and Anemia.

Authors:  Vivek Saroha; Cassandra D Josephson; Ravi Mangal Patel
Journal:  Clin Perinatol       Date:  2018-12-12       Impact factor: 3.430

Review 3.  Transfusion-related Gut Injury and Necrotizing Enterocolitis.

Authors:  Allison Thomas Rose; Vivek Saroha; Ravi Mangal Patel
Journal:  Clin Perinatol       Date:  2020-02-20       Impact factor: 3.430

4.  Long-term cardiovascular outcome following fetal anaemia and intrauterine transfusion: a cohort study.

Authors:  Alexandra H Wallace; Stuart R Dalziel; Brett R Cowan; Alistair A Young; Kent L Thornburg; Jane E Harding
Journal:  Arch Dis Child       Date:  2016-09-23       Impact factor: 3.791

5.  Preoperative Anemia and Neonates.

Authors:  Rosemary D Higgins; Ravi Mangal Patel; Cassandra D Josephson
Journal:  JAMA Pediatr       Date:  2016-09-01       Impact factor: 16.193

Review 6.  Research Opportunities to Improve Neonatal Red Blood Cell Transfusion.

Authors:  Ravi Mangal Patel; Erin K Meyer; John A Widness
Journal:  Transfus Med Rev       Date:  2016-07-04

7.  Red blood cell transfusions in preterm newborns and neurodevelopmental outcomes at 2 and 5 years of age.

Authors:  Camilla Fontana; Genny Raffaeli; Nicola Pesenti; Tiziana Boggini; Valeria Cortesi; Francesca Manzoni; Odoardo Picciolini; Monica Fumagalli; Fabio Mosca; Stefano Ghirardello
Journal:  Blood Transfus       Date:  2020-12-01       Impact factor: 3.443

Review 8.  Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis.

Authors:  Lars B Holst; Marie W Petersen; Nicolai Haase; Anders Perner; Jørn Wetterslev
Journal:  BMJ       Date:  2015-03-24

9.  Erythrocyte transfusions increased the risk of elevated serum ferritin in very low birthweight infants and were associated with altered longitudinal growth.

Authors:  Stina Alm; Elisabeth Stoltz Sjöström; Johan Nilsson Sommar; Magnus Domellöf
Journal:  Acta Paediatr       Date:  2020-01-09       Impact factor: 2.299

10.  Transfusion rates and disease spectrum in neonates treated with blood transfusion in China.

Authors:  Yang Sun; Ting Ma; Wen-Hua Wang; Qin Zhang; Zhen-Ai Jin; Jiang-Cun Yang
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.